WHO prequalifies arthritis drug for treatment of severe COVID cases
The World Health Organisation (WHO) has disclosed that it prequalified tocilizumab, a monoclonal antibody and arthritis drug for use in ...
The World Health Organisation (WHO) has disclosed that it prequalified tocilizumab, a monoclonal antibody and arthritis drug for use in ...
© 2022 WITHIN NIGERIA MEDIA LTD. designed by WebAndName
© 2022 WITHIN NIGERIA MEDIA LTD. designed by WebAndName